| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |